FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option

The Food and Drug Administration approved a new medicine for ALS from Amylyx Pharmaceuticals on Thursday, providing a desperately needed new treatment option for a devastating disease.

The medicine, to be sold as Relyvrio, is not a cure for ALS but proved to moderately slow the progression of the neurological disease, which causes the destruction of neurons in the brain and spinal cord, resulting in weakened muscles, paralysis, and death.

Read the rest…

Read Original Article: FDA approves ALS drug from Amylyx, giving patients a much-needed treatment option »